Antibody-Drug Conjugates

Antibody-Drug Conjugates

Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer

by Kenneth J. Olivier, Sara A. Hurvitz

560 pages· 2016· ISBN 9781119060802
Join Readfeed freeFind clubs reading this bookBrowse readable books
About
Providing practical and proven solutions for antibody-drug conjugate (ADC) drug discovery success in oncology, this book helps readers improve the drug safety and therapeutic efficacy of ADCs to kill targeted tumor cells. • Discusses the basics, drug delivery strategies, pharmacology and toxicology, and regulatory approval strategies • Covers the conduct and design of oncology clinical trials and the use of ADCs for tumor imaging • Includes case studies of ADCs in oncology drug development • Features contributions from highly-regarded experts on the frontlines of ADC research and development

Discuss Antibody-Drug Conjugates with other readers

Join or start a book club for Antibody-Drug Conjugates on Readfeed. Live chat, shared reading progress, and AI discussion questions — free to get started.

Sign up freeBrowse book clubs

Frequently asked questions

How do I join a book club for Antibody-Drug Conjugates?

Sign up free on Readfeed, then browse public clubs or start your own club with Antibody-Drug Conjugates as the current read. Invite friends with a share link and discuss together with live chat and AI discussion questions.

Can I discuss Antibody-Drug Conjugates with other readers online?

Yes. Readfeed book clubs let you chat live, share progress, and join discussions about Antibody-Drug Conjugates with readers worldwide — whether your club is virtual, in-person, or hybrid.

Is Readfeed free?

Yes. Creating an account and joining book clubs is free. Sign up to find readers who love the same books and start discussing today.